Menu
GeneBe

TRPV1

transient receptor potential cation channel subfamily V member 1, the group of Transient receptor potential cation channels|Ankyrin repeat domain containing

Basic information

Region (hg38): 17:3565443-3609411

Previous symbols: [ "VR1" ]

Links

ENSG00000196689NCBI:7442OMIM:602076HGNC:12716Uniprot:Q8NER1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TRPV1 gene.

  • Inborn genetic diseases (43 variants)
  • not provided (18 variants)
  • Malignant hyperthermia of anesthesia (1 variants)
  • Nephropathic cystinosis (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPV1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
3
clinvar
8
missense
1
clinvar
41
clinvar
6
clinvar
2
clinvar
50
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
2
clinvar
2
Total 0 1 42 11 7

Variants in TRPV1

This is a list of pathogenic ClinVar variants found in the TRPV1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-3566826-C-T not specified Uncertain significance (Feb 01, 2023)2471312
17-3566832-C-T not specified Uncertain significance (Aug 26, 2022)2403031
17-3566858-T-C not specified Uncertain significance (Mar 07, 2024)3183469
17-3566978-C-T not specified Uncertain significance (Jan 10, 2023)2461610
17-3571516-C-T Likely benign (Jun 13, 2018)726690
17-3571589-T-G not specified Uncertain significance (Apr 17, 2023)2537405
17-3572182-C-T not specified Uncertain significance (Jan 08, 2024)3183468
17-3572188-C-T Malignant hyperthermia of anesthesia Uncertain significance (Feb 26, 2021)1678638
17-3572231-C-A not specified Uncertain significance (Dec 12, 2023)3183466
17-3573719-T-G not specified Uncertain significance (Jun 30, 2022)2299284
17-3573863-C-T Likely benign (Jun 05, 2018)728409
17-3573871-C-T not specified Uncertain significance (Apr 19, 2023)2510634
17-3573879-A-C Benign (Apr 16, 2018)723409
17-3573890-A-G not specified Uncertain significance (May 11, 2022)2357808
17-3573898-G-A not specified Uncertain significance (Dec 28, 2023)3183465
17-3573900-C-T Benign (Jun 10, 2018)778654
17-3573901-G-A Likely benign (Jul 06, 2018)717635
17-3577139-G-C Likely benign (Jul 19, 2018)773586
17-3577170-C-T not specified Uncertain significance (Mar 07, 2024)3183464
17-3577612-C-T not specified Uncertain significance (Oct 20, 2023)3183463
17-3577644-G-T not specified Uncertain significance (Feb 13, 2024)3183462
17-3577668-C-T not specified Uncertain significance (Sep 07, 2022)2354558
17-3580491-T-C Benign (Jul 19, 2018)774344
17-3583394-G-T Likely benign (Aug 15, 2018)743037
17-3583414-T-G not specified Uncertain significance (Feb 13, 2023)2483115

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TRPV1protein_codingprotein_codingENST00000571088 1531655
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.01e-160.12712499601661251620.000663
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4664755040.9420.00003115421
Missense in Polyphen167176.580.945771848
Synonymous-1.432582301.120.00001681626
Loss of Function1.152936.50.7950.00000186417

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002070.00202
Ashkenazi Jewish0.0003100.000298
East Asian0.0006400.000608
Finnish0.001640.00162
European (Non-Finnish)0.0005550.000538
Middle Eastern0.0006400.000608
South Asian0.0003660.000359
Other0.0003310.000328

dbNSFP

Source: dbNSFP

Function
FUNCTION: Ligand-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. Involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius, exhibits a time- and Ca(2+)-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH <6) directly activate the channel. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid and bradykinin. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamine in the hippocampus and nucleus accumbens by affecting AMPA receptors endocytosis. {ECO:0000250|UniProtKB:O35433, ECO:0000269|PubMed:11050376, ECO:0000269|PubMed:11226139, ECO:0000269|PubMed:11243859, ECO:0000269|PubMed:12077606}.;
Pathway
Inflammatory mediator regulation of TRP channels - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Serotonin and anxiety;Stimuli-sensing channels;Ion channel transport;Transport of small molecules;TRP channels;Trk receptor signaling mediated by PI3K and PLC-gamma;Trk receptor signaling mediated by the MAPK pathway (Consensus)

Recessive Scores

pRec
0.258

Intolerance Scores

loftool
rvis_EVS
0.01
rvis_percentile_EVS
54.16

Haploinsufficiency Scores

pHI
0.111
hipred
N
hipred_score
0.146
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.801

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyLowLowLow
CancerLowLowLow

Mouse Genome Informatics

Gene name
Trpv1
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); taste/olfaction phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;fever generation;microglial cell activation;diet induced thermogenesis;peptide secretion;negative regulation of systemic arterial blood pressure;lipid metabolic process;cell surface receptor signaling pathway;chemosensory behavior;negative regulation of heart rate;negative regulation of mitochondrial membrane potential;glutamate secretion;cellular response to heat;positive regulation of apoptotic process;response to peptide hormone;positive regulation of nitric oxide biosynthetic process;behavioral response to pain;sensory perception of mechanical stimulus;thermoception;detection of temperature stimulus involved in thermoception;detection of temperature stimulus involved in sensory perception of pain;detection of chemical stimulus involved in sensory perception of pain;release of sequestered calcium ion into cytosol;protein homotetramerization;excitatory postsynaptic potential;smooth muscle contraction involved in micturition;positive regulation of gastric acid secretion;calcium ion transmembrane transport;cellular response to alkaloid;cellular response to ATP;cellular response to tumor necrosis factor;cellular response to acidic pH;cellular response to temperature stimulus;negative regulation of establishment of blood-brain barrier;calcium ion import across plasma membrane;response to capsazepine;cellular response to nerve growth factor stimulus
Cellular component
mitochondrion;cytosol;plasma membrane;integral component of plasma membrane;external side of plasma membrane;integral component of membrane;cell junction;intrinsic component of plasma membrane;dendritic spine membrane;neuronal cell body;postsynaptic membrane
Molecular function
transmembrane signaling receptor activity;ion channel activity;extracellular ligand-gated ion channel activity;excitatory extracellular ligand-gated ion channel activity;calcium channel activity;protein binding;calmodulin binding;ATP binding;calcium-release channel activity;chloride channel regulator activity;phosphatidylinositol binding;identical protein binding;metal ion binding;phosphoprotein binding;temperature-gated ion channel activity